Articles

Impact of dose intensity on outcome of fludarabine, cyclophosphamide, and rituximab regimen given in the first-line therapy for chronic lymphocytic leukemia

Department of Hematology, Purpan University Hospital, Toulouse
Department of Hematology, Purpan University Hospital, Toulouse
Department of Hematology, Purpan University Hospital, Toulouse
Department of Hematology, Purpan University Hospital, Toulouse
Department of Hematology, Claude Huriez University Hospital, Lille
Hospices Civils de Lyon, Hematology Department, Lyon-Sud University Hospital, Pierre-Bénite, France
Department of Hematology, Purpan University Hospital, Toulouse
Department of Hematology, Purpan University Hospital, Toulouse
Vol. 98 No. 1 (2013): January, 2013 https://doi.org/10.3324/haematol.2012.070755